2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lymphoma
3
Uterine Cervical Neoplasms
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Head and Neck Neoplasms
2
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Small Cell Lung Carcinoma
1
Precancerous Conditions
1
Pancreatitis, Chronic
1
Pancreatic Cyst
1
Mouth Diseases
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hematuria
1
Gastrointestinal Stromal Tumors
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Cervical Intraepithelial Neoplasia Grade 2/3
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Biopsy, Fine-Needle
1
Anus Neoplasms
1
Interventions
pembrolizumab
91
Gemcitabine
56
Nivolumab
50
Cisplatin
39
atezolizumab
37
Carboplatin
30
avelumab
29
enfortumab vedotin
25
Docetaxel
23
Magnetic Resonance Spectroscopy
19
Mitomycin
17
Ipilimumab
17
Paclitaxel
16
Specimen Handling
14
durvalumab
11
toripalimab
10
sacituzumab govitecan
10
Pemetrexed
10
cabozantinib
9
Taxes
8
vinflunine
7
Cyclophosphamide
7
tislelizumab
6
Injections
6
Bevacizumab
6
pemigatinib
5
fludarabine
5
disitamab vedotin
5
Standard of Care
5
Radiosurgery
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Cytological Techniques
×
Clear all
NCT07037589
2025-11-21
BLUSH
Vastra Gotaland Region
Recruiting
300 enrolled